Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (61-70 of 308) with videos related to

Pageof 31
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Conditional Financing of Drugs in the Netherlands: Past, Present, and Future-Results From Stakeholder InterviewsAmr Makady, Sandine van Acker, Hugo Nijmeijer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 27, 2022
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitusTalip E Eroglu, Ruben Coronel, Coert J Zuurbier, et al.
Pediatric Diabetes|April 25, 2017
Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort studySoulmaz Fazeli Farsani, Heshu Abdullah-Koolmees, Patrick C Souverein, et al.
The Journal of Pharmacy and Pharmacology|May 22, 2010
Methodological and statistical issues in pharmacogenomicsBas J M Peters, Andrei S Rodin, Anthonius de Boer, et al.
Expert Review of Cardiovascular Therapy|August 14, 2009
Genetic determinants of response to statinsBas J M Peters, Olaf H Klungel, Anthonius de Boer, et al.
Plos One|February 18, 2014
Essential medicines are more available than other medicines around the globeYaser T Bazargani, Margaret Ewen, Anthonius de Boer, et al.
Pharmacy World & Science : PWS|September 28, 2004
Pre-randomization decisions and group stratification in a randomized controlled trial to improve prescribingMartine E C van Eijk, Arsenio H P Paes, Arijan Porsius, et al.
Clinical Trials (London, England)|January 23, 2025
Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials RegulationAmos J de Jong, Helga Gardarsdottir, Yared Santa-Ana-Tellez, et al.
British Journal of Clinical Pharmacology|August 26, 2004
Recent trends in (under)treatment of hypercholesterolaemia in the NetherlandsAukje K Mantel-Teeuwisse, W M Monique Verschuren, Olaf H Klungel, et al.
Pharmacoepidemiology and Drug Safety|December 14, 2020
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort studyFatma Rustem Gulluoglu, Patrick C Souverein, Hendrika A van den Ham, et al.
Pageof 31

Showing results (61-70 of 308) with videos related to

Sort By:
Pageof 31
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Conditional Financing of Drugs in the Netherlands: Past, Present, and Future-Results From Stakeholder InterviewsAmr Makady, Sandine van Acker, Hugo Nijmeijer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 27, 2022
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitusTalip E Eroglu, Ruben Coronel, Coert J Zuurbier, et al.
Pediatric Diabetes|April 25, 2017
Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort studySoulmaz Fazeli Farsani, Heshu Abdullah-Koolmees, Patrick C Souverein, et al.
The Journal of Pharmacy and Pharmacology|May 22, 2010
Methodological and statistical issues in pharmacogenomicsBas J M Peters, Andrei S Rodin, Anthonius de Boer, et al.
Expert Review of Cardiovascular Therapy|August 14, 2009
Genetic determinants of response to statinsBas J M Peters, Olaf H Klungel, Anthonius de Boer, et al.
Plos One|February 18, 2014
Essential medicines are more available than other medicines around the globeYaser T Bazargani, Margaret Ewen, Anthonius de Boer, et al.
Pharmacy World & Science : PWS|September 28, 2004
Pre-randomization decisions and group stratification in a randomized controlled trial to improve prescribingMartine E C van Eijk, Arsenio H P Paes, Arijan Porsius, et al.
Clinical Trials (London, England)|January 23, 2025
Experiences with low-intervention clinical trials-the new category under the European Union Clinical Trials RegulationAmos J de Jong, Helga Gardarsdottir, Yared Santa-Ana-Tellez, et al.
British Journal of Clinical Pharmacology|August 26, 2004
Recent trends in (under)treatment of hypercholesterolaemia in the NetherlandsAukje K Mantel-Teeuwisse, W M Monique Verschuren, Olaf H Klungel, et al.
Pharmacoepidemiology and Drug Safety|December 14, 2020
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort studyFatma Rustem Gulluoglu, Patrick C Souverein, Hendrika A van den Ham, et al.
Pageof 31